Showing results (141-150 of 221) with videos related to

Sort By:
Pageof 23
Drug Discoveries & Therapeutics|December 10, 2025
A phase II investigator-initiated, continuation trial of 5-aminolevulinic acid hydrochloride/sodium ferrous citrate (5-ALA-HCl/SFC) for patients with adult-onset Still's disease (AOSD) refractory to glucocorticoidsRemi Sumiyoshi, Tomohiro Koga, Osamu Kamisawa, et al.
Modern Rheumatology|January 5, 2016
A twin study of rheumatoid arthritis in the Japanese populationChikashi Terao, Katsunori Ikari, Shingo Nakayamada, et al.
Scientific Reports|October 15, 2021
Serum vitamin D status inversely associates with a prevalence of severe sarcopenia among female patients with rheumatoid arthritisHiroto Minamino, Masao Katsushima, Mie Torii, et al.
Lupus|March 29, 2021
Validation and verification of the Japanese version of the systemic lupus erythematosus symptom checklist for patient quality of lifeHiroshi Doi, Koichiro Ohmura, Yuya Tabuchi, et al.
Cureus|September 19, 2025
A Phase-II Investigator-Initiated Randomized, Double-Blind, Parallel-Group Clinical Trial of 5-Aminolevulinic Acid Hydrochloride/Sodium Ferrous Citrate (5-ALA-HCl/SFC) for Patients With Adult-Onset Still's Disease (AOSD) Refractory to CorticosteroidsRemi Sumiyoshi, Tomohiro Koga, Osamu Kamisawa, et al.
Scientific Reports|July 21, 2017
Time-averaged disease activity fits better joint destruction in rheumatoid arthritisHideaki Tsuji, Koichiro Yano, Moritoshi Furu, et al.
Plos One|April 8, 2015
Periodontitis and Porphyromonas gingivalis in preclinical stage of arthritis patientsMotomu Hashimoto, Toru Yamazaki, Masahide Hamaguchi, et al.
Journal of Internal Medicine|September 22, 2025
Long-term efficacy of rituximab versus intravenous cyclophosphamide for severe ANCA-associated vasculitis in multicenter REVEAL cohort studyShogo Matsuda, Takuya Kotani, Daisuke Nishioka, et al.
Arthritis Research & Therapy|May 8, 2019
Correction to: Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort studyKosuke Ebina, Motomu Hashimoto, Wataru Yamamoto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 18, 2015
Brief Report: Main Contribution of DRB1*04:05 Among the Shared Epitope Alleles and Involvement of DRB1 Amino Acid Position 57 in Association With Joint Destruction in Anti-Citrullinated Protein Antibody-Positive Rheumatoid ArthritisChikashi Terao, Koichiro Yano, Katsunori Ikari, et al.
Pageof 23